Natera’s Advancements in ctDNA/MRD and Signatera’s Potential Drive Buy Rating
Leerink Partners analyst Puneet Souda has maintained their bullish stance on NTRA stock, giving a Buy rating yesterday.Invest with Confidence: ...
CNN1y
Natera, Inc.
Natera, Inc. is a diagnostics company ... genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
Business Insider23d
Natera’s Strong Market Position and Growth Potential Drive Buy Rating
Natera (NTRA) Company Description ... Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded ...
Natera, Inc. (NASDAQ:NTRA) Shares Sold by SG Americas Securities LLC
SG Americas Securities LLC reduced its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 39.8% in the 4th quarter, ...
FY2024 EPS Estimates for Natera Increased by Leerink Partnrs
Leerink Partnrs boosted their FY2024 earnings per share estimates for Natera in a report released on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now forecasts that the medical research ...
Hosted on MSN1mon
‘Anora,' One of the Most Acclaimed Films of the Year, Is Now Available on Digital Platforms
His latest film, Anora, is his most commercially successful to date and also one of his most acclaimed. It won the 2024 Palm d'Or at Cannes and earned strong reviews from critics, and it's now ...
Yahoo Finance1mon
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
AUSTIN, Texas, January 07, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the 43rd Annual J.P. Morgan ...